2016
DOI: 10.1161/atvbaha.116.307830
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis

Abstract: Objective-Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown.Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice. Approach and Results-Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α-expressing macrophages in murine atherosclero… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
106
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 118 publications
(114 citation statements)
references
References 71 publications
8
106
0
Order By: Relevance
“…As mentioned, MLN4924 increases LPSinduced HIF-1α levels in endothelial cells, which corresponds with a previous observation of increased HIF activity in the kidney of LPS-treated mice (26). Interestingly, endothelial HIF-1α had been found to promote atherosclerosis and enhance leukocyte adhesion, and myeloid HIF-1α was seen to promote or not affect atherosclerotic lesion formation (60,72,73). With respect to our study, this could imply that increased HIF-1α may begin to counteract initial NF-κB-associated atheroprotective effects of MLN4924 implicated in early atherosclerosis and explain the absence of atheroprotection in more advanced lesions.…”
Section: /Apoesupporting
confidence: 89%
“…As mentioned, MLN4924 increases LPSinduced HIF-1α levels in endothelial cells, which corresponds with a previous observation of increased HIF activity in the kidney of LPS-treated mice (26). Interestingly, endothelial HIF-1α had been found to promote atherosclerosis and enhance leukocyte adhesion, and myeloid HIF-1α was seen to promote or not affect atherosclerotic lesion formation (60,72,73). With respect to our study, this could imply that increased HIF-1α may begin to counteract initial NF-κB-associated atheroprotective effects of MLN4924 implicated in early atherosclerosis and explain the absence of atheroprotection in more advanced lesions.…”
Section: /Apoesupporting
confidence: 89%
“…4,83,84 At the beginning of atherosclerosis, monocytes, which are attracted by the chemokines secreted by resident vascular cells, migrate into the subendothelial area where they differentiate into macrophages on growth factors stimulation. 83 In the atherosclerotic lesions, macrophages ingest oxidized LDL through scavenger receptors and become lipid-laden foam cells.…”
Section: Monocytes/macrophagesmentioning
confidence: 99%
“…47,48 Hypoxia promotes glucose uptake by macrophages and potentiates glycolysis in parallel with the development of a proinflammatory M1 phenotype (essentially increased NOS2), dependent on HIF1α expression and 6-phosphofructo-2-kinase. 47,49 Deletion of HIF1α in murine myeloid cells (granulocytes and macrophages) does not affect the development of early atherosclerotic lesions 48 but significantly limits the accumulation of M1-like macrophages and reduces the development of advanced atherosclerosis. 47 This contrasts with the role of HIF1α in CD11c + antigen-presenting cells where it seems to limit proatherogenic Th1 cells through STAT3-dependent inhibition of interleukin-12 (IL-12) production.…”
Section: Innate Immune Functionsmentioning
confidence: 99%
“…47,49 Deletion of HIF1α in murine myeloid cells (granulocytes and macrophages) does not affect the development of early atherosclerotic lesions 48 but significantly limits the accumulation of M1-like macrophages and reduces the development of advanced atherosclerosis. 47 This contrasts with the role of HIF1α in CD11c + antigen-presenting cells where it seems to limit proatherogenic Th1 cells through STAT3-dependent inhibition of interleukin-12 (IL-12) production. 48 In another study, inhibition of HIF-inducible prolyl 4-hydroxylase-2 in HIF-P4H-2-hypomorphic/C699Y-Ldlr −/− mice or using an oral small molecule inhibitor induced a stabilization of HIF1α and HIF2α and led to a reduction of atherosclerosis.…”
Section: Innate Immune Functionsmentioning
confidence: 99%